One such destination is the stunning island of Syros, which is just 23 nautical miles and a 30-minute ferry ride from Mykonos. Covering an area of just 32 square miles, it is home to around 21,000 ...

Rege Nephro has announced that it has successfully acquired Tamibarotene-related clinical and non-clinical assets from Syros Pharmaceuticals (SYRS), through a mutual agreement. The acquisition was ...

Syros Pharmaceuticals has previously carried out a Phase 3 clinical trial of Tamibarotene for indications including myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). This ...